Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Counting lung cancer cells ‘could offer insight into disease progression’

Counting lung cancer cells ‘could offer insight into disease progression’

23rd March 2011

A new study has discovered that counting the number of circulating tumour cells (CTCs) among lung cancer patients can help to inform decisions about the severity of their condition.

Scientists from Cancer Research UK have discovered that the number of CTCs in blood samples can provide an indication of how likely a patient is to survive and how aggressive their cancer may be.

The research, which appeared in the Journal of Clinical Oncology, suggests that this method could be used as a simple means of monitoring a patient's progress over time, allowing doctors to check how well they are responding to treatment.

Currently, clinicians are reliant on invasive bronchoscopy procedures to make lung cancer diagnoses, which are only performed once and cannot be used for continuous assessment.

Dr Lesley Walker, director of cancer information at Cancer Research UK, added that the discovery of these cells' role in cancer progression could also open up new avenues for drug research and development.

Earlier this month, the organisation published statistics showing that lung cancer rates among women over 60 have doubled since the mid-1970s.ADNFCR-8000103-ID-800473355-ADNFCR

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.